- Preparetion of BK-VP1 virus-like particles and their characterization2005 | Faculty of Science
- Nanotechnology Interventions in the Management of COVID-19: Prevention, Diagnosis and Virus-Like Particle Vaccines2021 | Publication without faculty affiliation
- Preparation and analysis of chimeric virus-like particles derived from mouse polyomavirus +22006 | Faculty of Science
- Human papillomavirus genotype spectrum in Czech women: Correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles1999 | Publication without faculty affiliation
- Bcr-Abl fusion sequences do not induce immune responses in mice when administeredin mouse polyomavirus based virus-like particles2009 | Faculty of Science, First Faculty of Medicine, Faculty of Mathematics and Physics
- The Protein Corona Does Not Influence Receptor-Mediated Targeting of Virus-like Particles2020 | Faculty of Science, Central Library of Charles University
- Murine Polyomavirus VP1 Virus-like Particles Immunize against some Polyomavirus-induced Tumours.2005 | Faculty of Science
- Vaccination against influenza - history, current situation and future trends2011 | Third Faculty of Medicine
- Tailoring the polyomavirus into an efficient gene and drug delivery vehiclePublication without faculty affiliation
- Applications of Viral Nanoparticles2015 | Faculty of Science
- Point mutation in calcium-binding domain of mouse polyomavirus VP1 protein does not prevent virus-like particle formation, but changes VP1 interactions with Saccharomyces cerevisiae cell structures.2005 | Faculty of Science
- Construction of chimeric polyomavirus-like particles carrying epitopes of fusion protein BCR-ABL2005 | Faculty of Science
- Use of polyomavirus-like particles for development of vaccine as a supportive treatment of chronic myeloid leukemia2005 | Faculty of Science
- Point mutation in calcium -binding domain of mouse polyomavirus VP1protein does not prevent virus-like particle formation, but changes VP1 interactions with Saccharomyces cerevisiae cell structures2005 | Faculty of Science
- The role of the DE and EF loop of BKPyV VP1 in the serological cross-reactivity between subtypes2023 | Faculty of Science
- Inhibitor-GCPII Interaction: Selective and Robust System for Targeting Cancer Cells with Structurally Diverse Nanoparticles.Publication without faculty affiliation
- Inhibitor-GCPII Interaction: Selective and Robust System for Targeting Cancer Cells with Structurally Diverse Nanoparticles2018 | Faculty of Science, Faculty of Physical Education and Sport, Central Library of Charles University
- Retargeting Polyomavirus-Like Particles to Cancer Cells by Chemical Modification of Capsid Surface2017 | Faculty of Science, Faculty of Physical Education and Sport
- Polyomavirus EGFP-pseudocapsids: Analysis of model particles for introduction of proteins and peptides into mammalian cells2005 | Second Faculty of Medicine
- Mason-Pfizer Monkey Virus Envelope Glycoprotein Cycling and Its Vesicular Co-Transport with Immature Particles2018 | Publication without faculty affiliation
- Prevalence of antibodies against BKPyV subtype I and IV in kidney transplant recipients and in the general Czech population2019 | Faculty of Science
- Defective viral genomes from chikungunya virus are broad-spectrum antivirals and prevent virus dissemination in mosquitoes2021 | Faculty of Pharmacy in Hradec Králové
- Prospective study on cervical neoplasia: presence of HPV DNA in cytological smears precedes the development of cervical neoplastic lesions2003 | Third Faculty of Medicine
- Exploitation of stable nanostructures based on the mouse polyomavirus for development of a recombinant vaccine against porcine circovirus 22017 | Faculty of Science
- Cellular and humoral immune responses to chimeric EGFP-pseudocapsids derived from the mouse polyomavirus after their intranasal administration2008 | Faculty of Science
- Vaccine based on VLP structure of bovinne papillomavirus 1Publication without faculty affiliation
- Yeast: Model for studies of cell-cell communication and multicellular structure interactions1999 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Cell-penetrating peptides in the intracellular delivery of viral nanoparticles2021 | Faculty of Science